TERT and urinary bladder cancer: The TERT C228T mutation has been shown to be significantly associated with the prognosis of bladder cancer, particularly with bladder recurrence in NMIBC14, whereas TERT C250 mutation appears to be an independent predictive marker of response to BCG treatment15.